NEJM Reports on 2 New Drugs for Hepatitis C

Last week’s NEJM delivered an intriguing, imperfect article on a new approach to treating hepatitis C (HCV). The paper’s careful title, Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1, seems right. The analysis, with 17 authors listed, traces the response of 21 people with hepatitis C (HCV) who got two new anti-viral agents, with or […]

Posted in Academic Medicine, clinical trials, Infectious DiseaseTagged , , , , , , , , , 1 Comment on NEJM Reports on 2 New Drugs for Hepatitis C

News on an Unusual Cancer Treatment by Heat in Surgery (Hipec)

There’s so much weird and exciting cancer news this week, it’s hard to keep up! Double-kudos to Andrew Pollack on his front-page and careful coverage in the New York Times of the hyperthermic intraperitoneal chemotherapy (Hipec) technique that’s being used at some name-brand health care facilities to treat colon cancer. First, he spares no detail […]

Posted in cancer treatment, Communication, Medical News, Oncology (cancer)Tagged , , , , , , , , , 7 Comments on News on an Unusual Cancer Treatment by Heat in Surgery (Hipec)

NIH to Drop Requirement for Websites Disclosing Researchers’ Ties to Industry

Today’s word comes from Nature News that the NIH is dropping a proposed requirement for universities to disclose researchers’ financial ties to industry on websites. This is a loss for patients, who may not be aware of their doctors’ relationships with pharmaceutical companies and others who fund clinical trials, fellowships, conference junkets and other perks […]

Posted in Academic Medicine, clinical trials, Communication, Informed Consent, PolicyTagged , , , , , , , , , 1 Comment on NIH to Drop Requirement for Websites Disclosing Researchers’ Ties to Industry
newsletter software